BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7508264)

  • 1. Identification of an IgE-binding determinant of the major allergen Myr p I from the venom of the Australian jumper ant Myrmecia pilosula.
    Donovan GR; Street MD; Baldo BA; Alewood D; Alewood P; Sutherland S
    Biochim Biophys Acta; 1994 Jan; 1204(1):48-52. PubMed ID: 7508264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of a major allergen (Myr p I) from the venom of the Australian jumper ant, Myrmecia pilosula.
    Donovan GR; Baldo BA; Sutherland S
    Biochim Biophys Acta; 1993 Jan; 1171(3):272-80. PubMed ID: 7678752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilosulins: a review of the structure and mode of action of venom peptides from an Australian ant Myrmecia pilosula.
    Wanandy T; Gueven N; Davies NW; Brown SG; Wiese MD
    Toxicon; 2015 May; 98():54-61. PubMed ID: 25725257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence.
    Street MD; Donovan GR; Baldo BA
    Biochim Biophys Acta; 1996 Feb; 1305(1-2):87-97. PubMed ID: 8605256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards complete identification of allergens in Jack Jumper (Myrmecia pilosula) ant venom and their clinical relevance: An immunoproteomic approach.
    Wanandy T; Wilson R; Gell D; Rose HE; Gueven N; Davies NW; Brown SGA; Wiese MD
    Clin Exp Allergy; 2018 Sep; 48(9):1222-1234. PubMed ID: 29975807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of major peptides in 'jack jumper' ant venom by mass spectrometry.
    Davies NW; Wiese MD; Brown SG
    Toxicon; 2004 Feb; 43(2):173-83. PubMed ID: 15019477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myrmecia pilosula (Jack Jumper) ant venom: identification of allergens and revised nomenclature.
    Wiese MD; Brown SG; Chataway TK; Davies NW; Milne RW; Aulfrey SJ; Heddle RJ
    Allergy; 2007 Apr; 62(4):437-43. PubMed ID: 17362256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products.
    Donovan GR; Street MD; Tetaz T; Smith AI; Alewood D; Alewood P; Sutherland SK; Baldo BA
    Biochem Mol Biol Int; 1996 Aug; 39(5):877-85. PubMed ID: 8866004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate allergic reactions to Myrmecia ant stings: immunochemical analysis of Myrmecia venoms.
    Street MD; Donovan GR; Baldo BA; Sutherland S
    Clin Exp Allergy; 1994 Jun; 24(6):590-7. PubMed ID: 7922779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of jumper ant (Myrmecia pilosula) venom allergens: a novel group of highly basic proteins.
    Donovan GR; Street MD; Baldo BA
    Electrophoresis; 1995 May; 16(5):804-10. PubMed ID: 7588566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.
    Wanandy T; Dwyer HE; McLean L; Davies NW; Nichols D; Gueven N; Brown SGA; Wiese MD
    Clin Exp Allergy; 2017 Nov; 47(11):1478-1490. PubMed ID: 28756642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy.
    Wiese MD; Davies NW; Chataway TK; Milne RW; Brown SG; Heddle RJ
    J Pharm Biomed Anal; 2011 Jan; 54(2):303-10. PubMed ID: 20869831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myrmecia pilosula (Jack Jumper) ant venom: validation of a procedure to standardise an allergy vaccine.
    Wiese MD; Milne RW; Davies NW; Chataway TK; Brown SG; Heddle RJ
    J Pharm Biomed Anal; 2008 Jan; 46(1):58-65. PubMed ID: 17933477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of jack-jumper ant (Myrmecia pilosula) venom allergens.
    Ford SA; Baldo BA; Weiner J; Sutherland S
    Clin Exp Allergy; 1991 Mar; 21(2):167-71. PubMed ID: 2043985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based epitope prediction and assessment of cross-reactivity of Myrmecia pilosula venom-specific IgE and recombinant Sol g proteins (Solenopsis geminata).
    Buraphaka H; Dobutr T; Wiese MD; Lopata AL; Daduang S
    Sci Rep; 2024 May; 14(1):11145. PubMed ID: 38750087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilosulin 5, a novel histamine-releasing peptide of the Australian ant, Myrmecia pilosula (Jack Jumper Ant).
    Inagaki H; Akagi M; Imai HT; Taylor RW; Wiese MD; Davies NW; Kubo T
    Arch Biochem Biophys; 2008 Sep; 477(2):411-6. PubMed ID: 18544336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hymenoptera venom allergens.
    Hoffman DR
    Clin Rev Allergy Immunol; 2006 Apr; 30(2):109-28. PubMed ID: 16645223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural requirements of epitopes with IgE binding capacity demonstrated by three major allergens from fish, egg and tree pollen.
    Elsayed S; Apold J; Holen E; Vik H; Florvaag E; Dybendal T
    Scand J Clin Lab Invest Suppl; 1991; 204():17-31. PubMed ID: 1710368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula.
    Wu QX; King MA; Donovan GR; Alewood D; Alewood P; Sawyer WH; Baldo BA
    Biochim Biophys Acta; 1998 Sep; 1425(1):74-80. PubMed ID: 9813247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of Myrmecia pilosula (jack jumper) ant venom.
    Wiese MD; Chataway TK; Davies NW; Milne RW; Brown SG; Gai WP; Heddle RJ
    Toxicon; 2006 Feb; 47(2):208-17. PubMed ID: 16376960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.